UnitedHealth Group will announce its Q2 2026 earnings on Thursday, July 16, before the market opens. The company has experienced a strong start to 2026, with its stock rising about 30% year-to-date.
Analysts on Wall Street predict earnings per share (EPS) to be between $4.84 and $4.85, reflecting an 18.6% increase compared to the same quarter last year. Revenue estimates are set between $110.05 billion and $110.76 billion, indicating a decline of approximately 1.4% from Q2 2025.
Market participants expect significant volatility, with options traders pricing in a potential 6.27% movement in either direction following the earnings release.
Key Metrics and Member Counts
Another critical figure to observe will be the Medical Care Ratio, which analysts forecast to be around 88.6%, a slight improvement over the 89.4% reported in the same quarter the previous year. A lower ratio typically suggests that the company is managing its medical costs more efficiently relative to premiums.
Revenue forecasts have been segmented into key business areas, with premium revenues estimated at $85.93 billion, representing a 2.2% year-over-year decline. Services revenues are anticipated to reach $9.55 billion, a 5.6% increase from last year, while products revenue is expected at $13.68 billion, reflecting a 0.9% growth. Additionally, investment and other income are forecasted at $1.03 billion, showing a 7.3% drop.
Membership figures will also be in focus, with the total domestic commercial members forecasted to decline to 29.53 million, down from 29.97 million a year ago. Risk-based commercial members are projected to decrease to 7.26 million, while fee-based commercial members may rise to 22.27 million.
Stability in consensus EPS estimates over the past month suggests that analysts remain confident in their projections, although the options market indicates that investors are preparing for potential surprises.
This material is for informational purposes only and should not be considered financial advice.
